Search -

Displaying 1 - 20 of 52

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

Presenter: Konstantinos Voudris

October 30, 2024

Presentation TCT 2022

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

Presenter: Sina Salehi Omran

September 18, 2022

Session I: Innovation and Practice in Structural Heart Intervention - Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Presentation TCT 2019

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Liwen Liu

September 25, 2019

Presentation TCT 2017

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

Presenter: Brij Maini, Petr Neuzil, Christopher Capps, MD

October 31, 2017

Presentation TCT 2016

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

Severe AS and Hypertrophic Cardiomyopathy

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, Paul Sorajja

October 31, 2016

Presentation TCT 2014

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Israel Guerrero Mantilla, MD

September 16, 2014

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Presentation TCT 2014

Interventional Perspective: Not Surgery of Course!

Presenter: Carey D. Kimmelstiel

September 16, 2014

Presentation TCT 2014

Surgeon's Perspective on HOCM surgery

Presenter: John D. Puskas

September 16, 2014

Presentation TCT 2014

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Complications of Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

Patient Management Post Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh, Valerian Fernandes

September 16, 2014

Presentation TCT 2014

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

September 16, 2014

Presentation TCT 2014

When to Consider Septal Reduction Therapy

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann

September 16, 2014

Presentation TCT 2014

Sudden Cardiac Death and Atrial Fibrillation in HCM

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Kishore J. Harjai

September 16, 2014

Presentation TCT 2014

Hemodynamics of Dynamic Obstruction

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, James B. Hermiller Jr

September 16, 2014

Presentation TCT 2014

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Rod H. Stables

September 16, 2014

Presentation TCT 2014

Epidemiology and Genetics

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Carolyn Ho

September 16, 2014

Advertisement

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

Severe AS and Hypertrophic Cardiomyopathy

TCT 64: Coil Embolization for Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Long-term Results

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Interventional Perspective: Not Surgery of Course!

Surgeon's Perspective on HOCM surgery

Long-term Outcomes Following Alcohol Septal Ablation: Is the Procedure Durable?

Complications of Alcohol Septal Ablation

Patient Management Post Ablation

HCM Ablation Step-by-Step and Avoiding Potential Pitfalls

Case Selection and Use of Myocardial Contrast Echocardiography During Ablation

When to Consider Septal Reduction Therapy

Sudden Cardiac Death and Atrial Fibrillation in HCM

Hemodynamics of Dynamic Obstruction

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Epidemiology and Genetics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content